Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 4 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Dupuytren Contracture 4Contracture 1

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × xiapex × Clear all
NCT01407068 2017-10-05

Administration of Two Injections for Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
60 enrolled 12 charts

Dupuytren Contracture

NCT01674634 2017-10-05

Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures

Endo Pharmaceuticals

Phase 3 Completed
715 enrolled 17 charts

Contracture, Dupuytren Contracture

NCT01588353 2017-03-21

CORD-J

Asahi Kasei Therapeutics Corporation

Phase 3 Completed
104 enrolled 13 charts

Dupuytren Contracture

NCT01229436 2014-03-17

POINT X

Pfizer

Phase 3 Completed
254 enrolled 28 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡